Cho L, Nicholls SJ, Nordestgaard BG, Landmesser U, et al. Design and rationale of Lp(a)HORIZON trial: Assessing the effect of Lipoprotein(a) lowering with Pelacarsen on major cardiovascular events in patients with CVD and elevated Lp(a). Am Heart J 2025 Apr 2:S0002-8703(25)00101-2. doi: 10.1016/j.ahj.2025.
PMID: 40185318